Efficacy of Fosfomycin-Containing Regimens for Treatment of Bacteremia Due to Pan-Drug Resistant <i>Acinetobacter baumannii</i> in Critically Ill Patients: A Case Series Study
<i>Acinetobacter baumannii</i> (AB) has evolved over the last decades as a major problem in carbapenem-resistant gram-negative nosocomial infections, associated with high mortality rates especially in the intensive care unit (ICU). Recent reports highlight the increasing prevalence of re...
Main Authors: | Stelios F. Assimakopoulos, Vassilis Karamouzos, Gerasimos Eleftheriotis, Maria Lagadinou, Christina Bartzavali, Fevronia Kolonitsiou, Fotini Paliogianni, Fotini Fligou, Markos Marangos |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | Pathogens |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-0817/12/2/286 |
Similar Items
-
Oral Antibiotics for Bacteremia and Infective Endocarditis: Current Evidence and Future Perspectives
by: Gerasimos Eleftheriotis, et al.
Published: (2023-12-01) -
Laboratory Surveillance of <i>Acinetobacter</i> spp. Bloodstream Infections in a Tertiary University Hospital during a 9-Year Period
by: Anastasia Spiliopoulou, et al.
Published: (2023-11-01) -
Synergistic activity of fosfomycin–meropenem and fosfomycin–colistin against carbapenem resistant Klebsiella pneumoniae: an in vitro evidence
by: Yamuna Devi Bakthavatchalam, et al.
Published: (2020-04-01) -
Impact of Tigecycline’s MIC in the Outcome of Critically Ill Patients with Carbapenemase-Producing <i>Klebsiella pneumoniae</i> Bacteraemia Treated with Tigecycline Monotherapy—Validation of 2019′s EUCAST Proposed Breakpoint Changes
by: Matthaios Papadimitriou-Olivgeris, et al.
Published: (2020-11-01) -
Incidence of Carbapenem-Resistant Gram-Negative Bacterial Infections in Critically Ill Patients with COVID-19 as Compared to Non-COVID-19 Patients: A Prospective Case-Control Study
by: Diamanto Aretha, et al.
Published: (2024-01-01)